GlobeNewswire Inc | Nov 11, 2021 04:30PM EST

November 11, 2021

SAN DIEGO, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that management will present a Company overview at the following upcoming virtual investor conferences in November:

Jefferies 2021 London Healthcare ConferenceDate: Thursday, November 18, 2021Time: On-demand webcast available beginning 8:00 a.m. GMT (3:00 a.m. ET)

4th Annual Evercore ISI HealthCONx ConferenceDate: Tuesday, November 30, 2021Time: 10:30 a.m. ET

Live webcasts will be available at https://ir.travere.com/events-presentations and archived replays will be accessible for up to 30 days.

About Travere Therapeutics

At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope today and tomorrow. For more information, visit travere.com

Contact:Chris Cline, CFA

Senior Vice President, Investor Relations & Corporate Communications888-969-7879

IR@travere.com